BETAMETHASONE VALERATE
Generic: Betamethasone Valerate
- NDC
- 68788-8496
- ICD-10 indication
- L30.9
Affordability Check
How much will you actually pay for BETAMETHASONE VALERATE?
In 30 seconds, see every legitimate way to afford BETAMETHASONE VALERATE — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About BETAMETHASONE VALERATE
What is this medication? Betamethasone valerate is a topical corticosteroid medication primarily used to treat a wide variety of inflammatory skin conditions. It is available in several preparations, such as creams, ointments, lotions, and foams, which allows it to be applied effectively to different areas of the body. This medication is designed to manage and reduce symptoms like persistent itching, redness, and swelling associated with various types of skin irritation. This medication works by suppressing the immune response and inhibiting the release of natural substances in the body that cause inflammation. It is commonly prescribed for patients suffering from conditions such as eczema, psoriasis, seborrheic dermatitis, and severe allergic rashes. Because it is considered a medium to high potency steroid, it is typically used for short-term relief to improve the appearance and comfort of the affected skin.
Copay & patient assistance
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Betamethasone Valerate.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup BETAMETHASONE VALERATE →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for Betamethasone Valerate →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Prescribing information
From the FDA-approved label for BETAMETHASONE VALERATE. Official source: DailyMed (NLM) · Label effective Mar 19, 2026
Indications and usage
Dosage and administration
Contraindications
Adverse reactions
Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
- Dermatitis信号通路检测在评估药物对细胞信号传导影响中的应用十分广泛。通过对特定信号分子的激活或抑制情况进行分析,研究人员可以深入了解药物的作用机制、疗效及潜在毒副作用。以下是信号通路检测在药物研发不同阶段的具体应用及常用检测方法。 ### 1. 信号通路检测在药物研发中的应用 #### A. 药物筛选与活性评价 在新药开发的早期阶段,利用基于信号通路的细胞模型筛选具有生物活性的先导化合物。通过观察药物对特定信号通路(如MAPK、PI3K/Akt、NF-κB等)的调控能力,初步判定其治疗潜力。 #### B. 作用机制研究(MOA) 一旦筛选出具有活性的化合物,需要深入研究其具体的分子靶点及所影响的下游通路。信号通路检测可以揭示药物是如何通过层层传递的信号最终引起细胞生理反应的(如凋亡、增殖或分化)。 #### C. 耐药机制研究 长期用药往往会导致耐药性的产生,这通常与补偿性信号通路的激活有关。通过对比敏感细胞和耐药细胞的信号通路图谱,可以发现耐药的关键信号节点,为联合用药方案提供依据。 #### D. 安全性与毒性预测 某些信号通路(如p53通路的异常激活)是细胞损伤或基因毒性的指标。通过检测这些通路,可以在临床前阶段预测药物的安全性,减少开发风险。 --- ### 2. 常用信号通路检测技术 #### A. 蛋白质水平检测 由于信号传导多涉及蛋白质的磷酸化、乙酰化等翻译后修饰,蛋白质水平的检测是最直接的手段。 * **Western Blot (WB):** 检测特定信号蛋白及其磷酸化状态(如p-Akt/Akt比值)的经典方法。 * **酶联免疫吸附测定 (ELISA):** 用于定量检测细胞裂解液或血清中的关键信号分子或细胞因子。 * **高内涵筛选 (High-Content Screening
- Dermatitis
- HCS):** 利用荧光标记和自动化成像,观察蛋白在细胞内的定位(如NF-κB从胞质向胞核的转位)。 * **蛋白质组学/质谱技术:** 对药物处理前后的全细胞蛋白磷酸化水平进行系统性分析。 #### B. 基因水平与转录活性检测 信号通路的下游往往是基因表达的变化。 * **荧光素酶报告基因检测 (Luciferase Reporter Assay):** 将特定信号通路的反应元件(RE)与荧光素酶基因连接。若药物激活该通路,荧光强度增强。这是筛选通路激活剂或抑制剂的高效工具。 * **qPCR:** 检测通路下游靶基因mRNA表达量的变化。 * **转录组测序 (RNA-Seq):** 从整体水平观察药物对信号通路下游所有基因转录的影响。 #### C. 细胞功能水平检测 信号通路的改变最终体现为细胞行为的变化。 * **流式细胞术 (FCM):** 用于检测细胞周期分布、细胞凋亡比例以及胞内磷酸化蛋白。 * **细胞增殖与迁移实验 (CCK-8
- Eczema
- Transwell):** 评估药物通过信号通路对细胞生长和运动能力的影响。 --- ### 3. 应用实例:以肿瘤药物研发为例 假设研发一种针对EGFR突变的肺癌靶向药: 1. **筛选:** 检测候选药物是否能抑制细胞内EGFR的自磷酸化。 2. **验证:** 使用Western Blot检测下游通路蛋白(如ERK、Akt)的磷酸化水平是否随药物浓度增加而下降。 3. **转录水平:** 通过qPCR检测下游调控细胞周期的基因(如Cyclin D1)表达是否被抑制。 4. **耐药:** 若细胞产生耐药,检测是否由于Met通路的代偿性激活引起。 ### 总结 信号通路检测不仅是评价药物效果的“标尺”,更是解析生命过程、指导临床精准用药的重要工具。通过多维度、多技术的联合应用,可以构建出药物作用的完整图谱。
- Corticosteroid-responsive dermatoses
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Related drugs
DERMOTIC
Treats same condition · fluocinolone acetonide
Dupixent
Treats same condition · Dupilumab
Physician EZ Use Joint Tunnel and Trigger Kit
Treats same condition · AMMONIA, LIDOCAINE HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, POVIDONE-IODINE
Prednisolone Sodium Phosphate Oral Solution
Treats same condition · prednisoLONE sodium phosphate
VUSION
Treats same condition · miconazole nitrate, zinc oxide, white petrolatum
Marbeta L Kit
Treats same condition · Betamethasone Sodium Phosphate, Betamethasone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Isopropyl Alcohol
Lidocaine HCl - Hydrocortisone Acetate
Treats same condition · LIDOCAINE HCL - HYDROCORTISONE ACETATE
Urea 40%
Treats same condition · Urea
OvacePlus Plus
Treats same condition · SULFACETAMIDE SODIUM
Anzupgo
Treats same condition · delgocitinib
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.